Valuation AbbVie Inc.

Stocks

Market Closed - Nyse Other stock markets 21:02:20 08/06/2026 BST			After hours 01:00:00
223.07 ^USD	-1.83%		221.10	-0.89%

06-08	Abbvie Presents New Data Across Its Blood Cancer Portfolio At Eha 2026	CI
06-04	Wall Street's Chip Boom Gets a Warning

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	239,371	285,707	273,605	314,021	403,830	394,118	-	-
Change	-	19.36%	-4.24%	14.77%	28.6%	-2.4%	-	-
Enterprise Value (EV) ¹	306,225	339,749	320,176	375,610	463,570	447,982	438,187	425,557
Change	-	10.95%	-5.76%	17.31%	23.42%	-3.36%	-2.19%	-2.88%
P/E ratio	21x	24.4x	57x	74.4x	96.8x	27.3x	20.3x	17x
PBR	15.5x	16.6x	26.5x	94.8x	-124x	-812x	52.7x	21.8x
PEG	-	8.74x	-1x	-6.1x	-77.12x	0x	0.6x	0.9x
Capitalization / Revenue	4.27x	4.92x	5.04x	5.57x	6.6x	5.86x	5.42x	5.05x
EV / Revenue	5.46x	5.85x	5.89x	6.67x	7.58x	6.66x	6.03x	5.45x
EV / EBITDA	10.6x	11x	12.5x	15.6x	18.9x	13.6x	11.8x	10.4x
EV / EBIT	10.9x	11.3x	12.9x	16.1x	19.5x	14x	12.1x	10.7x
EV / FCF	13.9x	14x	14.5x	21.1x	26x	16.3x	13.5x	12.6x
FCF Yield	7.18%	7.14%	6.89%	4.75%	3.84%	6.13%	7.4%	7.93%
Dividend per Share ²	5.31	5.71	5.99	6.29	6.65	6.864	7.234	7.637
Rate of return	3.92%	3.53%	3.87%	3.54%	2.91%	3.08%	3.24%	3.42%
EPS ²	6.45	6.63	2.72	2.39	2.36	8.167	11	13.1
Distribution rate	82.3%	86.1%	220%	263%	282%	84%	65.8%	58.3%
Net sales ¹	56,122	58,054	54,318	56,334	61,160	67,225	72,705	78,078
EBITDA ¹	29,018	30,961	25,545	24,104	24,483	32,908	37,108	40,870
EBIT ¹	28,215	30,183	24,793	23,340	23,721	32,028	36,180	39,795
Net income ¹	11,542	11,836	4,863	4,278	4,226	14,855	19,309	22,342
Net Debt ¹	66,854	54,042	46,571	61,589	59,740	53,864	44,068	31,439
Reference price ²	135.40	161.61	154.97	177.70	228.49	223.07	223.07	223.07
Nbr of stocks (in thousands)	1,767,880	1,767,880	1,765,537	1,767,140	1,767,385	1,766,793	-	-
Announcement Date	02/02/22	09/02/23	02/02/24	31/01/25	04/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ABBVIE INC.	27.31x	6.66x	13.61x	3.08%	394B
ELI LILLY AND COMPANY	33.62x	12.22x	25.16x	0.59%	1,025B
JOHNSON & JOHNSON	24.81x	5.72x	15.56x	2.3%	559B
ROCHE HOLDING AG	17.31x	4.28x	10.51x	3.11%	324B
MERCK & CO., INC.	53.32x	4.96x	20.16x	2.8%	295B
ASTRAZENECA PLC	23.32x	4.83x	13.75x	1.81%	286B
NOVARTIS AG	20.51x	5.3x	12.89x	3.08%	270B
NOVO NORDISK A/S	12.03x	4.53x	9.26x	4.17%	186B
AMGEN INC.	22.48x	6.03x	10.53x	2.92%	187B
GILEAD SCIENCES, INC.	-45.84x	5.54x	31.24x	2.53%	159B
Average	18.89x	6.01x	16.27x	2.64%	368.53B
Weighted average by Cap.	24.91x	7.29x	17.71x	2.17%